Latest Kannada Business news : Brokerage house gave buy rating to HDFC, Sun Pharma and Exide, told target price of all three

New Delhi. Newbies investing in the stock market may feel that earning money in the market is not easy and this is also true to a large extent. But if you invest in good stocks by looking at the fundamentals, then earning money in the market can be somewhat easy. Big investors tend to look at the fundamentals in terms of quarterly results and year-on-year net profit.

Now since it is not the control of every common investor to read the fundamentals, then there are some companies or say brokerage houses, who keep telling you the fundamentals of different companies from time to time. Along with this, they also give advice on investing in a stock and also tell the target price of the stock. However, before investing in any stock in the stock market, it is good to consult a certified advisor.

Also Read – Brokerage House Bullish on Polycab India, Advised to Buy as Target

Motilal Oswal suggested these stocks
Today we are telling you three stocks recommended by Motilal Oswal, a big brokerage firm in India. This firm has given buy advice in all three stocks and has also given their targets. These three stocks include HDFC, Sun Pharma, and Exide.

Motilal Oswal has given a target price of Rs 2,830 for HDFC. On Monday, the stock of Housing Development Finance Corporation saw a slight rise on the NSE. The stock closed 0.25 percent higher at 2,383.75. The firm says that after the merger with HDFC Bank, it is a bit difficult to make a view on it alone, but it is going to be seen moving forward in its mortgage business as the management is working in this direction.

Also Read – Multibagger Stock: Fertilizers Company’s stock giving good returns

Rs 1,100 target for Sun Pharma
Apart from HDFC, the firm has listed one more share, which is named Sun Pharma. On Monday, the NSE fell 2.60 percent and closed at Rs 918.70. Motilal Oswal has given a target price of Rs 1,100 for this. The firm has said that Sun Pharma has shown good results in the first quarter of FY23. The company is expanding its specialty portfolio. Along with this, the brand is continuously working to build the franchise in the generics portfolio.

Apart from the above two stocks, Motilal Oswal has a buy call on Exide Industries. The firm has given a target of Rs 200 for this. On Monday, the stock of Exide fell 0.19 percent on the NSE to close at 158.20. This stock has been falling continuously for a long time. As per the chart of TradingView, it made a high of Rs 304.70 on 24th August 2018. The brokerage house has said that the company has shown good results in the first quarter of 2023 due to the tremendous revenue growth in the automotive and industrial segment.

(Disclaimer: The stocks mentioned here are based on the advice of brokerage houses. If you wish to invest in any of these, please consult a Certified Investment Advisor first. News18 will not be responsible for any profit or loss caused by you .)

Be the first to read breaking news in Hindi News18 Hindi | Today’s latest news, live news updates, read the most reliable Hindi news website News18 Hindi |

Tags: business news, Business news in hindi, Investment and return, Money Making Tips, stock market, Stock tips